Nanozyme Database

	ref	material	size	size err	size unit	size type	size comment	BET	b _nanozyme	b 10ⁿ	b unit	specific act	sa 10ⁿ	sa unit	comment
8141	1075	W-POM NCs					After a rapid reduction and stabilization process under the optimal reaction factors, W-POM NCs (2.0 ± 0.1 nm) were successfully obtained as evidenced by the transmission electron microscopy (TEM) characterization (Fig. 1a and S1). The slight increase in hydrated diameter (7.41 ± 0.67 nm) is attributed to the existence of hydrophilic gallic acid stabilizers which could further confirmed by their negative charged surface of around −27.2 mV (Fig. 1b and c).

	ref	material	enzyme type	substrate	pH	T	k_m	k_m err	k_m 10ⁿ	k_m unit	v_max	v_max err	v_max 10ⁿ	v_max unit	k_cat	k_cat err	k_cat 10ⁿ	k_cat unit	k_cat/k_m	k_cat/k_m 10ⁿ	k_cat/k_m unit	comment

	ref	material	application	target	method	linear range	linear ran unit	LOD	lod unit	recovery	comment
5986	1075	W-POM NCs	preventative and therapeutic drug for inflammatory bowel disease

	ref	title	DOI	material type	comment
4262	1075	Polyoxometalate Nanoclusters: A Potential Preventative and Therapeutic Drug for Inflammatory Bowel Disease	https://doi.org/10.1016/j.cej.2021.129137	Others	tungsten (W)-based polyoxometalate nanoclusters (W-POM NCs)